Edwards Lifesciences Revenue 2010-2023 | EW

Edwards Lifesciences annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Edwards Lifesciences revenue for the quarter ending December 31, 2023 was $1.534B, a 13.78% increase year-over-year.
  • Edwards Lifesciences revenue for the twelve months ending December 31, 2023 was $6.005B, a 11.56% increase year-over-year.
  • Edwards Lifesciences annual revenue for 2023 was $6.005B, a 11.56% increase from 2022.
  • Edwards Lifesciences annual revenue for 2022 was $5.382B, a 2.86% increase from 2021.
  • Edwards Lifesciences annual revenue for 2021 was $5.233B, a 19.29% increase from 2020.
Edwards Lifesciences Annual Revenue
(Millions of US $)
2023 $6,005
2022 $5,382
2021 $5,233
2020 $4,386
2019 $4,348
2018 $3,723
2017 $3,435
2016 $2,964
2015 $2,494
2014 $2,323
2013 $2,046
2012 $1,900
2011 $1,679
2010 $1,447
2009 $1,321
Edwards Lifesciences Quarterly Revenue
(Millions of US $)
2023-12-31 $1,534
2023-09-30 $1,481
2023-06-30 $1,530
2023-03-31 $1,460
2022-12-31 $1,348
2022-09-30 $1,319
2022-06-30 $1,374
2022-03-31 $1,341
2021-12-31 $1,330
2021-09-30 $1,310
2021-06-30 $1,376
2021-03-31 $1,217
2020-12-31 $1,192
2020-09-30 $1,141
2020-06-30 $925
2020-03-31 $1,129
2019-12-31 $1,174
2019-09-30 $1,094
2019-06-30 $1,087
2019-03-31 $993
2018-12-31 $978
2018-09-30 $907
2018-06-30 $944
2018-03-31 $895
2017-12-31 $889
2017-09-30 $822
2017-06-30 $842
2017-03-31 $884
2016-12-31 $768
2016-09-30 $739
2016-06-30 $759
2016-03-31 $697
2015-12-31 $671
2015-09-30 $616
2015-06-30 $617
2015-03-31 $590
2014-12-31 $618
2014-09-30 $607
2014-06-30 $575
2014-03-31 $522
2013-12-31 $536
2013-09-30 $496
2013-06-30 $517
2013-03-31 $497
2012-12-31 $511
2012-09-30 $448
2012-06-30 $482
2012-03-31 $459
2011-12-31 $430
2011-09-30 $413
2011-06-30 $431
2011-03-31 $405
2010-12-31 $392
2010-09-30 $349
2010-06-30 $365
2010-03-31 $341
2009-12-31 $347
2009-09-30 $326
2009-06-30 $336
2009-03-31 $314
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $51.712B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.122B 26.56
Intuitive Surgical (ISRG) United States $136.206B 85.53
IDEXX Laboratories (IDXX) United States $47.501B 56.77
IQVIA Holdings (IQV) United States $45.560B 26.94
DexCom (DXCM) United States $44.034B 75.64
Alcon (ALC) Switzerland $42.254B 31.16
STERIS (STE) Ireland $22.860B 27.06
Waters (WAT) United States $19.992B 28.74
SONOVA HOLDING (SONVY) Switzerland $18.460B 0.00
Hologic (HOLX) United States $17.398B 19.20
Sysmex ADR (SSMXY) Japan $11.504B 36.08
Fresenius Medical Care AG KGaA (FMS) Germany $11.332B 13.99
Teleflex (TFX) United States $10.578B 16.63
ShockWave Medical (SWAV) United States $9.819B 67.84
Penumbra (PEN) United States $8.930B 110.40
Globus Medical (GMED) United States $7.504B 23.37
Masimo (MASI) United States $6.801B 38.19
Glaukos (GKOS) United States $4.454B 0.00
Integer Holdings (ITGR) United States $3.616B 23.18
Inari Medical (NARI) United States $3.355B 582.60
Integra LifeSciences Holdings (IART) United States $3.023B 12.47
LivaNova (LIVN) United Kingdom $2.968B 19.60
Elekta AB (EKTAY) Sweden $2.716B 18.63
TransMedics (TMDX) United States $2.683B 0.00
PROCEPT BioRobotics (PRCT) United States $2.494B 0.00
Nihon Kohden (NHNKY) Japan $2.366B 20.01
RxSight (RXST) United States $2.024B 0.00
Alphatec Holdings (ATEC) United States $1.929B 0.00
Tandem Diabetes Care (TNDM) United States $1.744B 0.00
Veracyte (VCYT) United States $1.736B 0.00
Pacific Biosciences Of California (PACB) United States $1.490B 0.00
Paragon 28 (FNA) United States $1.005B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.98
Treace Medical Concepts (TMCI) United States $0.835B 0.00
Artivion (AORT) United States $0.786B 90.81
OPKO Health (OPK) United States $0.762B 0.00
SiBone (SIBN) United States $0.712B 0.00
Silk Road Medical (SILK) United States $0.689B 0.00
OrthoPediatrics (KIDS) United States $0.641B 0.00
Mesa Laboratories (MLAB) United States $0.578B 19.63
Pulse Biosciences (PLSE) United States $0.560B 0.00
Nevro (NVRO) United States $0.539B 0.00
IRadimed (IRMD) United States $0.519B 30.27
ORTHOFIX MEDICAL INC (OFIX) United States $0.482B 0.00
AxoGen (AXGN) United States $0.444B 0.00
NeuroPace (NPCE) United States $0.440B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.369B 12.51
Semler Scientific (SMLR) United States $0.330B 19.18
Accuray (ARAY) United States $0.259B 0.00
908 Devices (MASS) United States $0.242B 0.00
AngioDynamics (ANGO) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.213B 0.00
Alpha Tau Medical (DRTS) Israel $0.205B 0.00
Sight Sciences (SGHT) United States $0.200B 0.00
ClearPoint Neuro (CLPT) United States $0.190B 0.00
Inogen (INGN) United States $0.147B 0.00
Atossa Genetics (ATOS) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.115B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Delcath Systems (DCTH) United States $0.092B 0.00
EnVVeno Medical (NVNO) United States $0.089B 0.00
Neuronetics (STIM) United States $0.086B 0.00
Autonomix Medical (AMIX) $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.074B 149.67
SEP Acquisition (SEPA) United States $0.070B 0.00
Envoy Medical (COCH) United States $0.069B 0.00
Yubo Biotech (YBGJ) China $0.061B 0.00
DarioHealth (DRIO) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.060B 0.00
Vasomedical (VASO) United States $0.057B 4.41
Lucid Diagnostics (LUCD) United States $0.057B 0.00
LENSAR (LNSR) United States $0.056B 0.00
ReWalk Robotics (LFWD) Israel $0.053B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Pixie Dust Technologies (PXDT) Japan $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Ekso Bionics Holdings (EKSO) United States $0.029B 0.00
PAVmed (PAVM) United States $0.024B 0.00
PetVivo Holdings (PETV) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.019B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.007B 0.00
Avinger (AVGR) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00